ROS-mediated liposomal dexamethasone: a new FA-targeted nanoformulation to combat rheumatoid arthritis inhibiting iRhom2/TNF-α/BAFF pathways

Rheumatoid arthritis (RA) is an autoimmune inflammatory disorder that has seriously affected human health worldwide and its current management requires more successful therapeutic approaches. The combination of nanomedicines and pathophysiology into one system may provide an alternative strategy for...

Full description

Saved in:
Bibliographic Details
Published inNanoscale Vol. 13; no. 47; pp. 217 - 2185
Main Authors Song, Yanqin, Ismail, Muhammad, Shan, Qi, Zhao, Jianing, Zhu, Yanping, Zhang, Leiming, Du, Yuan, Ling, Longbing
Format Journal Article
Published 13.12.2021
Online AccessGet full text

Cover

Be the first to leave a comment!
You must be logged in first